AGP Executive Report
Last update: 10 hours agoCancer Care & Coverage: California enacted a law requiring insurance coverage for FDA-cleared scalp cooling for chemotherapy patients, joining a growing list of states pushing clearer access to supportive cancer treatments. Drug Safety & Research: Houston-based Moleculin published a peer-reviewed pooled cardiac safety analysis of Annamycin, reporting no clinical or subclinical cardiotoxicity signals at cumulative doses above traditional anthracycline limits. Mental Health & Access: Psyence BioMed says its Texas subsidiary secured an exclusive U.S. ibogaine license and distribution pathway, aiming to support development of ibogaine drug candidates. Maternal Health: Texas lawmakers are again criticizing delays tied to the state’s maternal health reporting, warning the lag could leave pregnant people without timely guidance. Healthcare Fraud: A North Texas clinic owner was convicted in a $26M TRICARE fraud scheme involving fake treatments and luxury purchases. Public Health in Prisons: New York reported a sharp rise in Narcan use after restricting physical mail in prisons, as overdose deaths remain elevated. Community Health Infrastructure: Texas Health Behavioral Health Center Denton is set to open in October, expanding local behavioral health capacity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
